Mefenorex
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Clinical data | |
---|---|
ATC code | A08AA09 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 17243-57-1 Y |
PubChem (CID) | 21777 |
ChemSpider | 20467 Y |
UNII | K98M4N387W Y |
KEGG | D07891 Y |
ECHA InfoCard | 100.037.511 |
Chemical and physical data | |
Formula | C12H18ClN |
Molar mass | 211.731 |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[1][2] Mefenorex produces amphetamine as a metabolite,[3] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[4]
References[edit]
- ^ Vincendeau MJ. A new regulator of appetite: mefenorex. (French). Bordeaux Medical. 1970 Jul-Aug;3(7):1951-3.
- ^ Beyer G, Huth K, Muller GM, Niemoller H, Raisp I, Vorberg G. The treatment of obesity with the appetite curbing agent Mefenorex. (German). Die Medizinische Welt. 1980 Feb;31(8):306-9.
- ^ Rendic S, Slavica M, Medic-Saric M. Urinary excretion and metabolism of orally administered mefenorex. European Journal of Drug Metabolism and Pharmacokinetics. 1994 Apr-Jun;19(2):107-17.
- ^ Engel J, Kristen G, Schaefer A, von Schlichtegroll A. Mefenorex (Rondimen). Drug and Alcohol Dependence. 1986 Jun;17(2-3):229-34.
α1 |
|
||||||
---|---|---|---|---|---|---|---|
α2 |
|
||||||
β |
|
||||||
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mefenorex&oldid=737816010"